British Columbia Investment Management Corp Teva Pharmaceutical Industries LTD Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $125,280 - $164,778	-17,400 Reduced 60.62%	11,302 $85,000
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $118,711 - $161,454	-14,200 Reduced 33.1%	28,702 $254,000
Q4 2022 Feb 10, 2023	SELL	$7.95 - $9.48 $15,105 - $18,012	-1,900 Reduced 4.24%	42,902 $391,000
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $36,358 - $63,334	5,300 Added 13.42%	44,802 $362,000
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $1,328 - $1,872	180 Added 0.46%	39,502 $297,000
Q1 2022 May 12, 2022	BUY	$7.33 - $9.39 $40,315 - $51,645	5,500 Added 16.26%	39,322 $369,000
Q2 2021 Aug 09, 2021	SELL	$9.9 - $11.56 $22,770 - $26,588	-2,300 Reduced 6.37%	33,822 $335,000
Q1 2021 Apr 30, 2021	SELL	$10.34 - $12.81 $31,020 - $38,430	-3,000 Reduced 7.67%	36,122 $417,000
Q4 2020 Feb 02, 2021	SELL	$8.61 - $11.04 $82,656 - $105,983	-9,600 Reduced 19.7%	39,122 $378,000
Q3 2020 Nov 10, 2020	SELL	$8.57 - $12.69 $64,275 - $95,175	-7,500 Reduced 13.34%	48,722 $439,000
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $186,759 - $301,760	-23,000 Reduced 29.03%	56,222 $693,000
Q1 2020 May 13, 2020	SELL	$6.69 - $13.45 $376,647 - $757,235	-56,300 Reduced 41.54%	79,222 $711,000
Q4 2019 Feb 12, 2020	BUY	$6.53 - $10.72 $118,846 - $195,104	18,200 Added 15.51%	135,522 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $229,768 - $358,080	-37,300 Reduced 24.12%	117,322 $807,000
Q2 2019 Aug 12, 2019	SELL	$8.12 - $15.72 $68,208 - $132,048	-8,400 Reduced 5.15%	154,622 $1.43 Million
Q1 2019 May 08, 2019	BUY	$15.58 - $20.01 $188,518 - $242,121	12,100 Added 8.02%	163,022 $2.56 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $450,831 - $736,656	-30,900 Reduced 16.99%	150,922 $2.33 Million
Q3 2018 Nov 13, 2018	SELL	$21.06 - $25.65 $682,344 - $831,060	-32,400 Reduced 15.12%	181,822 $3.92 Million
Q2 2018 Aug 09, 2018	SELL	$16.77 - $24.71 $1.26 Million - $1.85 Million	-74,883 Reduced 25.9%	214,222 $5.21 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $1.03 Million - $1.37 Million	62,000 Added 27.3%	289,105 $4.94 Million
Q4 2017 Feb 20, 2018	SELL	$11.23 - $19.1 $278,504 - $473,680	-24,800 Reduced 9.84%	227,105 $4.3 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $3.88 Million - $8.1 Million	251,905	251,905 $4.43 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$752 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$636 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$566 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$505 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$463 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account